# ChulaCov19 Vaccine in Healthy Adults

> **NCT04566276** · PHASE1,PHASE2 · COMPLETED · sponsor: **Chulalongkorn University** · enrollment: 192 (actual)

## Conditions studied

- COVID-19 Vaccine
- Safety Issues

## Interventions

- **BIOLOGICAL:** ChulaCov19 vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04566276
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-03
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-12-06
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2023-02-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04566276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04566276, "ChulaCov19 Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04566276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*